Commissural Alignment and Coronary Access after Transcatheter Aortic Valve Replacement.
Angelo Quagliana, Nicholas J Montarello, Yannick Willemen, Pernille S Bække, Troels H Jørgensen, Ole De Backer, Lars Sondergaard
Author Information
Angelo Quagliana: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark. ORCID
Nicholas J Montarello: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Yannick Willemen: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Pernille S Bække: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark. ORCID
Troels H Jørgensen: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Ole De Backer: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Lars Sondergaard: The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
中文译文
English
Transcatheter aortic valve implantation (TAVR) is the first therapeutic option for elderly patients with severe symptomatic aortic stenosis, and indications are steadily expanding to younger patients and subjects with lower surgical risk and longer life expectancy. Commissural alignment between native and transcatheter valves facilitates coronary access after TAVR and is thus considered a procedural goal, allowing long-term management of coronary artery disease. Moreover, commissural alignment may potentially have a positive impact on transvalvular hemodynamic and valve durability. This review focus on technical hints to achieve commissural alignment and current evidence for different transcatheter aortic valves.
JACC Cardiovasc Interv. 2022 Aug 8;15(15):1497-1518
[PMID: 35926918 ]
J Am Coll Cardiol. 2021 May 4;77(17):2187-2199
[PMID: 33926655 ]
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2523-2533
[PMID: 30573061 ]
JACC Cardiovasc Interv. 2020 Apr 27;13(8):938-950
[PMID: 32061612 ]
Eur Heart J. 2021 Aug 7;42(30):2912-2919
[PMID: 34179981 ]
JACC Cardiovasc Interv. 2020 Nov 9;13(21):2542-2555
[PMID: 33069648 ]
JACC Cardiovasc Interv. 2022 Jan 24;15(2):123-134
[PMID: 35057982 ]
JACC Cardiovasc Interv. 2020 May 11;13(9):1030-1042
[PMID: 32192985 ]
JACC Cardiovasc Interv. 2021 Oct 11;14(19):2097-2108
[PMID: 34538602 ]
JAMA Cardiol. 2022 Aug 1;7(8):866-872
[PMID: 35731530 ]
JACC Cardiovasc Interv. 2021 Apr 26;14(8):934-936
[PMID: 33640386 ]
J Am Coll Cardiol. 2018 Mar 27;71(12):1360-1378
[PMID: 29566822 ]
J Am Coll Cardiol. 2013 Jul 2;62(1):1-10
[PMID: 23644089 ]
JACC Cardiovasc Interv. 2021 Jun 14;14(11):1269-1272
[PMID: 34112468 ]
Circ Cardiovasc Interv. 2020 Feb;13(2):e008620
[PMID: 31992059 ]
JACC Cardiovasc Interv. 2018 Sep 10;11(17):1733-1743
[PMID: 30121280 ]
JACC Cardiovasc Interv. 2020 Mar 23;13(6):693-705
[PMID: 32192689 ]
Eur J Cardiothorac Surg. 2021 Nov 2;60(5):1139-1146
[PMID: 33942061 ]
Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E847-E854
[PMID: 33960624 ]
Cardiovasc Revasc Med. 2021 Jun;27:1-6
[PMID: 33129688 ]
EuroIntervention. 2022 Nov 18;18(10):822-823
[PMID: 35514218 ]
Int J Cardiol. 2015 Nov 15;199:253-60
[PMID: 26209948 ]
J Biomech. 2017 Feb 28;53:22-28
[PMID: 28118978 ]
Circulation. 2022 Aug 9;146(6):480-493
[PMID: 35862182 ]
Circ Cardiovasc Interv. 2022 Feb;15(2):e011045
[PMID: 35167332 ]
JACC Cardiovasc Interv. 2022 Jun 13;15(11):1126-1136
[PMID: 35680192 ]
J Am Coll Cardiol. 2019 Jul 23;74(3):362-372
[PMID: 31319919 ]
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2617-2627
[PMID: 33213747 ]
Catheter Cardiovasc Interv. 2018 Jan 1;91(1):115-123
[PMID: 28843025 ]
JACC Cardiovasc Interv. 2022 Jan 24;15(2):135-146
[PMID: 35057983 ]
App000092924/European Association of Percutaneous Cardiovascular Interventions (EAPCI Education & Training Grant).